Viridian Therapeutics (NASDAQ:VRDN) Price Target Lowered to $38.00 at JMP Securities
Viridian Therapeutics (NASDAQ:VRDN – Free Report) had its price target decreased by JMP Securities from $42.00 to $38.00 in a research report released on Wednesday,Benzinga reports. JMP Securities currently has a market outperform rating on the stock. A number of other equities research analysts have also weighed in on VRDN. Needham & Company LLC decreased […]
Viridian Therapeutics (NASDAQ:VRDN – Free Report) had its price target decreased by JMP Securities from $42.00 to $38.00 in a research report released on Wednesday,Benzinga reports. JMP Securities currently has a market outperform rating on the stock. A number of other equities research analysts have also weighed in on VRDN. Needham & Company LLC decreased […]
